Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness as well as the detrimental
influence of half-dose and half-fluence modification of verteporfin photodynamic therapy
(PDT) for the treatment of prolonged unresolved central serous chorioretinopathy (CSCR).